HMD — Heramed Cashflow Statement
0.000.00%
- AU$48.16m
- AU$46.79m
- AU$0.29m
Annual cashflow statement for Heramed, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Changes in Working Capital | 0.001 | 0.025 | 0.022 | 0.009 | 0.141 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.31 | -3.69 | -5.71 | -4.81 | -3.66 |
| Capital Expenditures | -0.114 | -0.996 | -0.002 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.114 | -0.996 | -0.002 | 0 | — |
| Financing Cash Flow Items | -0.159 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.51 | 3.66 | 3.04 | 6.88 | 1.91 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.21 | -1.36 | -2.88 | 2.07 | -1.76 |